Experiment 442047
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | HALBERG,E: LONG III,HJ: CONRNELISSEN,G: BLANK,MA: ELG,S: TOUITOU,Y: BAKKEN,E: DELMORE,P: HAUS,E: SACKETT-LUNDEEN,L: PREM,K: HALBERG,F:. (1992). TOWARD A CHRONOTHERAPY OF OVARIAN CANCER WITH TAXOL PART II: TEST PILOT STUDY ON CIRCULATING CA125.. 19(1/2) |
| Amount utilized | |
| Compound isolated | |
| Disease | DISCUSSED IS A CASE STUDY OF A 70 YEAR-OLD FEMALE WITH A WIDELY METASTATIC, UNDIFFERENTIATED (MUELLERIAN DUCT) ADENOCARCINOMA INVOLVING THE OVARY. PRIOR TO TAXOL TREATMENT THE PATIENT WAS GIVEN AN ARRAY OF CHEMOTHERAPY. THE PATIENT WAS GIVEN TWO SEPEARTE COURSES OF TAXOL WITH A DOSE OF 135 MG/SQ. M THROUGH CONTINOUS 24 HOURS INFUSION. ADMINISTRATION OF BOTH COURSES SHOWED A SIGNIFICANT DECREASE IN THE SERUM LEVELS OF CA125. |
| Dose amount | 135.0 MG |
| Number | 1 |
| Qualitative result | . |
| Animal | HUMAN ADULT |
| Per unit | SQ M |
| Dose expression | DOSE |